@article{dupuisgirod:hal-00991138, TITLE = {{ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.}}, AUTHOR = {Dupuis-Girod, S. and Ambrun, A. and Decullier, E. and Samson, G. and Roux, A. and Fargeton, A.-E. and Rioufol, C. and Schwiertz, V. and Disant, F. and Chapuis, F. and Donazzolo, Y. and Paintaud, G. and Edery, P. and Faure, F.}, URL = {https://univ-tours.hal.science/hal-00991138}, JOURNAL = {{mAbs}}, PUBLISHER = {{Taylor \& Francis}}, VOLUME = {6}, NUMBER = {3}, PAGES = {793-8}, YEAR = {2014}, MONTH = May, DOI = {10.4161/mabs.28025}, KEYWORDS = {Hereditary hemorrhagic telangiectasia ; Phase 1 clinical study ; bevacizumab ; epistaxis ; nasal spray ; monoclonal antibody}, PDF = {https://univ-tours.hal.science/hal-00991138/file/Ellipse12112013.pdf}, HAL_ID = {hal-00991138}, HAL_VERSION = {v1}, }